Reduction of Surgical-Site Infections in Cardiothoracic Surgery by Elimination of Nasal Carriage of Staphylococcus aureus
Infection Control and Hospital Epidemiology1996Vol. 17(12), pp. 780–785
Citations Over TimeTop 10% of 1996 papers
Jan Kluytmans, Johan W. Mouton, Marjolein Kluytmans-van den Bergh, Marie-Jose Manders, Alexander P.W.M. Maat, J. H. T. Wagenvoort, Marc Michel, Henri A. Verbrugh
Abstract
The results of this study indicate that perioperative elimination of nasal carriage using mupirocin nasal ointment significantly reduces the SSI rate in cardiothoracic surgery patients and warrants a prospective, randomized, placebo-controlled efficacy trial. This preventive measure may be beneficial in other categories of surgical patients as well.
Related Papers
- → Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial(2016)94 cited
- → Reduction in Inddence of Nosocomial Methicillin-Resistant Staphylococcus aureus (MRSA) Infection in an Intensive Care Unit: Role of Treatment With Mupirocin Ointment and Chlorhexidine Baths for Nasal Carriers of MRSA(2006)108 cited
- → First outbreak of community-acquired MRSA USA300 in France: failure to suppress prolonged MRSA carriage despite decontamination procedures(2014)30 cited
- → Genotypic and phenotypic characterization of methicillin-resistant Staphylococcus aureus (MRSA) clones with high-level mupirocin resistance(2016)22 cited
- → Universal Decolonization With Mupirocin Is Effective in Decreasement of Overall Hospital-Acquired Methicillin-Resistant Staphylococcus aureus Infection Rates(2015)